PTAB Poised To Take Up Hedge Fund Hijinks In Celgene Cases
The Patent Trial and Appeal Board's Monday decisions denying America Invents Act reviews of Acorda Therapeutics Inc.'s drug patents didn't address whether a group with hedge fund ties was improperly using...To view the full article, register now.
Already a subscriber? Click here to view full article